secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001493152-24-042964
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics raises $1.275M in private placement of common stock and warrants
--------------------------------------------------------------------------------

- Issued 1,948,295 shares (or pre-funded warrants) at $0.64 per share ($0.89 for insiders).
- Also issued Series A warrants (18-month term) and Series B warrants (5-year term), both exercisable at $0.64.
- Gross proceeds ~$1.275 million; net proceeds for working capital.
- Closing expected on or before November 4, 2024; Brookline Capital Markets acted as placement agent.
- Directors and officers subject to 90-day lock-up from closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224042964/0001493152-24-042964-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224042964/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042964

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer